Globus Medical GMED Neuromonitoring Services — Revenue
Discontinued — last reported Q3 '23
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Globus Medical’s 10-Q, filed November 7, 2023, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's neuromonitoring services — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's neuromonitoring services — revenue?
- Globus Medical (GMED) reported neuromonitoring services — revenue of $8.52M in Q3 2023.
- What does neuromonitoring services — revenue mean?
- Revenue earned from providing real-time nervous system monitoring services during surgical procedures.
- How do you interpret neuromonitoring services — revenue?
- An increase indicates higher adoption of the company's clinical support services and potentially higher utilization of its associated surgical hardware. A decrease may signal competitive pressure in the neuromonitoring space or a shift in hospital procurement preferences for outsourced clinical services.
- How does neuromonitoring services — revenue compare across companies?
- Comparable to clinical service revenue streams or specialized intraoperative support service lines found in other medical device companies that offer integrated surgical solutions.